Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mibe Pharma UK Ltd, 4 Coleman Street, 6th Floor; London, United Kingdom, EC2R 5AR
Solacutan 3% gel.
| Pharmaceutical Form |
|---|
|
Gel. Clear, transparent, colourless to yellowish. |
Each gram of gel contains 30 mg diclofenac sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
| List of Excipients |
|---|
|
Sodium hyaluronate |
Aluminium tube with original sealing membrane and internal protective lacquer and HDPE screw cap.
10 g gel
25 g gel
26 g gel
30 g gel
50 g gel
60 g gel
90 g gel
Not all pack sizes may be marketed.
Mibe Pharma UK Ltd, 4 Coleman Street, 6th Floor; London, United Kingdom, EC2R 5AR
PL 49452/0001
09.02.2017
| Drug | Countries | |
|---|---|---|
| SOLACUTAN | Austria, Spain, Italy, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
